glp-1 obesity injector components GLP-1-directed NMDA receptor antagonism for treatment GLP-1 Agonists Market Report 2025-2033,

Yes, major clinical trials have also shown that certain GLP-1s, like semaglutide, significantly reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes

Recently, medications known as GLP-1 agonists, including Ozempic, have become increasingly popular due to their ability to support meaningful weight loss, even among individuals without diabetes

Discomfort tends to be minimal and short-lived

This prolonged retention increases pressure, fullness, and discomfort, especially after larger, protein-dense, or high-fat meals, even though digestion continues normally and food is not physically blocked. Large meal volume and gastric distension Larger meal volumes cause the stomach to stretch